HORMOS MEDICAL OY LTD has a total of 49 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, New Zealand and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are GENFIT, AMARIN NEUROSCIENCE LTD and HORMOS MEDICAL CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | New Zealand | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Australia | 4 | |
#5 | Hungary | 4 | |
#6 | Canada | 3 | |
#7 | China | 3 | |
#8 | Czechia | 3 | |
#9 | Estonia | 3 | |
#10 | Norway | 3 | |
#11 | Brazil | 2 | |
#12 | Poland | 2 | |
#13 | EPO (European Patent Office) | 1 | |
#14 | Finland | 1 | |
#15 | Taiwan | 1 | |
#16 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Agriculture | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Measuring microorganism processes | |
#4 | Peptides | |
#5 | Animal care | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Heterocyclic compounds | |
#8 | Enzymes | |
#9 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Karvonen Matti | 24 |
#2 | Uusitupa Matti | 24 |
#3 | Koulu Markku | 24 |
#4 | Pesonen Ullamari | 23 |
#5 | Kangas Lauri | 15 |
#6 | Lammintausta Risto | 14 |
#7 | Santti Risto | 11 |
#8 | Streng Tomi | 11 |
#9 | Halonen Kaija | 10 |
#10 | Talo Antti | 9 |
Publication | Filing date | Title |
---|---|---|
AU6237801A | Method for treating cryptorchidism | |
FI20010927A0 | Process for the preparation of a therapeutically active substance | |
US2003077800A1 | ARIP4 gene and protein | |
TW593256B | Triphenylalkene derivatives and their use as selective estrogen receptor modulators | |
US6245819B1 | Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause | |
US6312898B1 | Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y gene | |
CZ20002214A3 | DNA molecule encoding mutant prepro-neuropeptide Y, mutant signal peptide and their use | |
CZ20002138A3 | Use of aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethal sphincter dyssynergia in men and method to study the dyssynergia in male rodents | |
US6046317A | DNA molecule encoding a mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof | |
US5972921A | Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men |